Novo Nordisk
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.About NVO
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments.
NVO Key Statistics
NVO News
Novo Nordisk’s weight-loss drug sales are slumping so much that the entire nation of Denmark could see an export slowdown Sales of Novo Nordisk’s obesity drugs...
Guggenheim raised the firm’s price target on Eli Lilly (LLY) to $936 from $928 and keeps a Buy rating on the shares after detailing how the firm is thinking abo...
Novo is offering a one-month sale on Wegovy and its partner telehealth platforms are offering creative ways to squeeze in a margin for themselves. Wegovy, the...
Analyst ratings
61%
of 31 ratingsMore NVO News
Novo Nordisk (NVO) isn’t just changing CEOs — it’s pulling a seasoned heavyweight back into the ring to help decide who comes next. Former chief Lars Rebien Sør...
Only half of health insurer Cigna 's clients currently cover the popular GLP-1 weight loss drugs Wegovy and Zepbound because of their high costs. But the compan...
To drugmakers' disdain, telehealth providers have pushed "personalized" versions of GLP-1s, which they might be able to continue selling after May 22. Pharmaci...
